-- 週二,美國股指期貨走高,交易員密切關注美伊之間可能重啟新一輪談判的不確定性,並等待最新一批企業財報。 標普500指數和道瓊工業指數在盤前交易中均上漲0.2%,那斯達克指數上漲0.3%。標普500指數和那斯達克指數在前一交易日均收跌,其中納斯達克指數結束了先前連續13個交易日的上漲勢頭,而道瓊斯指數則基本持平。 根據彭博社報道,美國總統川普表示,副總統約翰·迪·萬斯已準備好前往巴基斯坦,與伊朗舉行第二輪和平談判。然而,伊朗方面尚未公開確認是否會有代表參與最新提出的談判。 伊朗議會議長穆罕默德·巴格爾·加利巴夫週一在X網站上發帖稱:「我們不接受在威脅陰影下進行的談判,過去兩週,我們已準備好在戰場上亮出新的底牌。」伊朗總統馬蘇德·佩澤什基安也在社交媒體上發帖稱,伊朗對美國政府的行為仍然抱有「根深蒂固的歷史性不信任」。 根據彭博社報道,川普週一表示,如果未能達成協議,美國不太可能延長與伊朗目前的停火協議。據報道,川普稱,停火協議將於「華盛頓時間週三晚間」到期。 據彭博社報道,川普在一次電話採訪中表示:“我不會倉促達成一項糟糕的協議。我們有的是時間。” 麥格理集團週一在一份報告中指出,美伊停火協議可能會延長最多兩週,但達成全面的和平協議則需要更長的時間。 西德州中質原油(WTI)開盤前下跌1.2%至每桶88.55美元,布蘭特原油下跌0.9%至每桶86.68美元。 荷蘭國際集團(ING)週一發布的報告稱:“中東局勢再次劇烈波動,看似緩和的局面迅速演變為局勢再度升級。” 美國公債殖利率在盤前交易中走高,兩年期公債殖利率上漲2.1個基點至3.74%,十年期公債殖利率小幅上漲0.6個基點至4.26%。 通用電氣航空航太公司(GE)、聯合健康集團(UNH)、丹納赫公司(DHR)、諾斯羅普·格魯曼公司(NOC)、3M公司(MMM)、霍頓公司(DHI)、拖拉機供應公司(TSCO)和原廠配件公司(GPC)等公司將於開盤前公佈最新財務業績。 亞馬遜 (AMZN) 股價盤前上漲 2.7%,此前這家電商巨頭宣布將向人工智慧新創公司 Anthropic 投資 50 億美元,如果達到某些商業里程碑,未來還將追加至多 200 億美元投資。 蘋果 (AAPL) 股價小幅下跌 0.3%,此前這家 iPhone 製造商宣布蒂姆·庫克將卸任首席執行官一職,轉任執行董事長,硬件工程資深人士約翰·特納斯將接任首席執行官。阿拉斯加航空 (ALK) 在公佈最新季度業績後下跌 2.9%。 週二的經濟日程包括:美國東部時間上午 8:30 公佈 3 月份零售銷售報告,隨後是上午 10:00 公佈的同月成屋銷售指數。 聯準會主席提名人凱文沃什將在參議院銀行委員會舉行聽證會,聽證會定於上午 10 點舉行。聯準會理事克里斯多福沃勒預計將於下午 2:30 發表演說。 黃金價格下跌 0.6%,至每盎司 4,801 美元,而比特幣價格上漲 0.4%,至每盎司 76,575 美元。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.